Symbolbild · KI-generiert
CCL Industries Inc. Unlimited Class A Voting Shares
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
CCL Industries Inc manufactures and sells packaging and packaging-related products. The company operates through various segments, which include The CCL segment, which generates the majority of revenue, sells pressure sensitive and extruded film materials used for labels on consumer packaging, healthcare, automotive, and consumer durable products. The Avery segment sells software, labels, tags, dividers, badges, and specialty card products under the Avery brand. The Checkpoint segment includes the manufacturing and selling of technology-driven, inventory management and labeling solutions. Innovia segment manufactures specialty films. Its geographical segments include Canada; USA and Puerto Rico; Mexico, Brazil, Chile & Argentina; Europe; and Asia, Australia, Africa & New Zealand.
Company description as published by the issuer via TMX Money.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| CCL Industries Inc. Unlimited Class A Voting Shares | CCL.A | TSX | 774 Mio. USD |
| Anteris Technologies Global Corp. | AVR | NASDAQ | 763 Mio. USD |
| SI-BONE, Inc. | SIBN | NASDAQ | 788 Mio. USD |
| Design Therapeutics, Inc. | DSGN | NASDAQ | 761 Mio. USD |
| CryoPort, Inc. | CYRX | NASDAQ | 761 Mio. USD |
| Solid Biosciences Inc. | SLDB | NASDAQ | 794 Mio. USD |
| SpyGlass Pharma, Inc. | SGP | NASDAQ | 753 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.